These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7365317)

  • 1. Measurement of the carbamylation kinetics and antisickling mechanism in hemoglobin S blood.
    Uvelli DA; Lee MY; Manning JM; Hlastala MP; Babb AL
    J Lab Clin Med; 1980 May; 95(5):748-58. PubMed ID: 7365317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the cyanate-hemoglobin reaction in whole blood.
    Uvelli DA; Fry DL; Finch CA; Babb AL
    J Lab Clin Med; 1977 May; 89(5):978-86. PubMed ID: 16070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
    Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
    Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.
    Deiderich DA; Trueworthy RC; Gill P; Cader AM; Larsen WE
    J Clin Invest; 1976 Sep; 58(3):642-53. PubMed ID: 956392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylation distributions in extracorporeal treatment of sickle cell anemia.
    Uvelli DA; Agodoa LC; Babb AL
    J Lab Clin Med; 1978 Jun; 91(6):939-47. PubMed ID: 650059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo.
    Njikam N; Jones WM; Nigen AM; Gillette PN; Williams RC; Manning JM
    J Biol Chem; 1973 Dec; 248(23):8052-6. PubMed ID: 4752945
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP; Grever MR; Sing DE; Bishop JN; Segal ML
    J Lab Clin Med; 1982 Sep; 100(3):345-55. PubMed ID: 7108349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of nucleation and growth of sickle cell hemoglobin fibers.
    Galkin O; Nagel RL; Vekilov PG
    J Mol Biol; 2007 Jan; 365(2):425-39. PubMed ID: 17069853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the catalytic mechanism of staphylococcal lipases using carbamate substrates: chain length selectivity, interfacial activation, and cofactor dependence.
    Simons JW; Boots JW; Kats MP; Slotboom AJ; Egmond MR; Verheij HM
    Biochemistry; 1997 Nov; 36(47):14539-50. PubMed ID: 9398172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylisocyanate as an antisickling agent and its reaction with hemoglobin S.
    Lee CK
    J Biol Chem; 1976 Oct; 251(20):6226-31. PubMed ID: 977566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies hybrid HbS: complete neutralization of Val6(beta)-dependent polymerization of human beta-chain by pig alpha-chains.
    Rao MJ; Malavalli A; Manjula BN; Kumar R; Prabhakaran M; Sun DP; Ho NT; Ho C; Nagel RL; Acharya AS
    J Mol Biol; 2000 Jul; 300(5):1389-406. PubMed ID: 10903876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some comparative aspects of carbamylation of human blood and of hemoglobin with cyanate and carbamyl phosphate.
    Carreras-Barnes J; Diederich DA; Grisolia S
    Eur J Biochem; 1972 May; 27(1):103-8. PubMed ID: 5049047
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyanate and hemoglobin-S: effect of carbamylation of the alpha and beta chain alpha-amino groups on O2 affinity.
    Rossi F; Perrella M; Bresciani D; Guglielmo G; Rossi-Bernardi L
    FEBS Lett; 1975 Jul; 55(1):99-101. PubMed ID: 237798
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration.
    Stroncek DF; Byrne KM; Noguchi CT; Schechter AN; Leitman SF
    Transfusion; 2004 Sep; 44(9):1293-9. PubMed ID: 15318851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen transport in thin layers of packed sickle erythrocytes.
    Liu CY; Udden MM; Hellums JD
    Microvasc Res; 1995 Jan; 49(1):78-96. PubMed ID: 7746165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life span of carbamylated red cells in sickle cell anemia.
    Milner PF; Charache S
    J Clin Invest; 1973 Dec; 52(12):3161-71. PubMed ID: 4750447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.